Causal inference using observational intensive care unit data: a systematic review and recommendations for future practice
Smit, J. M.; Krijthe, J. H.; van Bommel, J.; Labrecque, J. A.; Komorowski, M.; Gommers, D. A. M. P. J.; Reinders, M. J. T.; van Genderen, M. E.
Show abstract
AimTo review and appraise the quality of studies that present models for causal inference of time-varying treatment effects in the adult intensive care unit (ICU) and give recommendations to improve future research practice. MethodsWe searched Embase, MEDLINE ALL, Web of Science Core Collection, Google Scholar, medRxiv, and bioRxiv up to March 2, 2022. Studies that present models for causal inference that deal with time-varying treatments in adult ICU patients were included. From the included studies, data was extracted about the study setting and applied methodology. Quality of reporting (QOR) of target trial components and causal assumptions (ie, conditional exchangeability, positivity and consistency) were assessed. Results1,714 titles were screened and 60 studies were included, of which 36 (60%) were published in the last 5 years. G methods were the most commonly used (n=40/60, 67%), further divided into inverse-probability-of-treatment weighting (n=36/40, 90%) and the parametric G formula (n=4/40, 10%). The remaining studies (n=20/60, 33%) used reinforcement learning methods. Overall, most studies (n=36/60, 60%) considered static treatment regimes. Only ten (17%) studies fully reported all five target trial components (ie, eligibility criteria, treatment strategies, follow-up period, outcome and analysis plan). The treatment strategies and analysis plan components were not (fully) reported in 38% and 48% of the studies, respectively. The causal assumptions (ie, conditional exchangeability, positivity and consistency) remained unmentioned in 35%, 68% and 88% of the studies, respectively. All three causal assumptions were mentioned (or a check for potential violations was reported) in only six (10%) studies. Sixteen studies (27%) estimated the treatment effect both by adjusting for baseline confounding and by adjusting for baseline and treatment-affected time-varying confounding, which often led to substantial changes in treatment effect estimates. ConclusionsStudies that present models for causal inference in the ICU were found to have incomplete or missing reporting of target trial components and causal assumptions. To achieve actionable artificial intelligence in the ICU, we advocate careful consideration of the causal question of interest, the use of target trial emulation, usage of appropriate causal inference methods and acknowledgement (and ideally examination of potential violations) of the causal assumptions. Systematic review registrationPROSPERO (CRD42022324014)
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials 94%
- Comparison of preprints and final journal publications from COVID-19 Studies: Discrepancies in results reporting and spin in interpretation 94%
- GPT for RCTs?: Using AI to measure adherence to reporting guidelines 93%
Similar papers in this journal
- Using numerical modelling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample 93%
- Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU) 93%
- Detailed disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic: An exploratory analysis 93%
Similar papers in this journal
- Statistical Analysis Plan for the Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients (SCREEN): a study protocol for a stepped-wedge cluster randomized controlled trial 94%
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 94%
- Electronic early notification of sepsis in hospitalized ward patients: a study protocol for a stepped-wedge cluster randomized controlled trial 93%
Similar papers in this journal
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 95%
- Evaluation of statistical methods used to meta-analyse results from interrupted time series studies: a simulation study 95%
- Development of the Individual Participant Data (IPD) Integrity Tool for assessing the integrity of randomised trials using individual participant data 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.